Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.
about
Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applicationsCancer nanomedicine: from targeted delivery to combination therapyLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Composite nanoparticles for gene delivery.Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.Hybrid lipid-polymer nanoparticles for sustained siRNA delivery and gene silencing.Development of multinuclear polymeric nanoparticles as robust protein nanocarriers.Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.In vivo sustained release of siRNA from solid lipid nanoparticles.Microfluidic based high throughput synthesis of lipid-polymer hybrid nanoparticles with tunable diametersMicrofluidic synthesis of rigid nanovesicles for hydrophilic reagents deliveryLong-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.Multifunctional nanocapsules for simultaneous encapsulation of hydrophilic and hydrophobic compounds and on-demand releaseUltra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer EfficacyMultifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects.Nanomedicines for Endothelial Disorders.Targeted polymeric therapeutic nanoparticles: design, development and clinical translationLiposome-like Nanostructures for Drug Delivery.Accelerating the Translation of Nanomaterials in Biomedicine.Therapeutic strategies based on polymeric microparticles.Recent progress in copolymer-mediated siRNA delivery.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectorsMicrofluidics-mediated assembly of functional nanoparticles for cancer-related pharmaceutical applications.Biodegradable Inorganic Nanovector: Passive versus Active Tumor Targeting in siRNA Transportation.Cationic α-cyclodextrin:poly(ethylene glycol) polyrotaxanes for siRNA delivery.Multi-armed cationic cyclodextrin:poly(ethylene glycol) polyrotaxanes as efficient gene silencing vectors.Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery.A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection.Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery.Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.Core-shell nanoparticles: synthesis and applications in catalysis and electrocatalysis.Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents DeliveryPreparation of particulate polymeric therapeutics for medical applications
P2860
Q28076544-BCF19C26-EFD8-4EA7-8572-D109A50CB1F2Q28083065-DCCDEA82-48AF-45B5-AD33-1BD96BE91E8CQ30366990-1271B5FA-2A69-4281-A48D-985164FA0890Q30374988-42D3371F-E4B6-440C-93C8-319FC8EF4F58Q30432272-CB53F9EB-8895-480A-A36E-009EF5438476Q33831440-009B6471-42B9-4C52-8C8E-D035C1051508Q34083382-F13BA55B-5F99-41AD-803C-2E22C0F938B4Q34440323-58001766-3EFF-4847-BD05-E5CEF7B7E93BQ35635763-AD8F8C7F-89EF-4886-BDB3-CEA9B7E3F3E8Q35693292-6F8C2C3B-84E9-4769-B37D-3ED7771D609BQ35753701-2AE010B2-DF8B-45CE-AF75-22083E6D4EDBQ35796255-39589155-EBFD-47B3-A75B-D1A130D7AC2BQ35857162-F128D6C7-59A1-4A8B-ACA8-41F5DE26D6B1Q36007248-67EDF8FC-2D06-4550-BAF6-E3FA1415588AQ36291372-726998C1-BD0E-4A70-88AA-E511B6794FD2Q36644318-A5B4703C-4F69-4E2C-888C-C1D574B9F316Q36651592-C3000879-214A-407B-ACEE-329631817996Q36934007-3E403B1E-2BA4-4571-9E4D-D914147B1244Q37424654-7CDFC656-494E-4B92-8CD6-51043C5C65B2Q37581374-5BB74291-F1E1-431E-8F50-5F9575AE9725Q38016146-2235D6F4-4D17-44C8-8901-9A3D9F41AD4CQ38023545-7E31E666-DC4B-43D6-8BD9-CA529AC15637Q38150118-0C93570D-B556-4D9C-80AE-1F788E0B7400Q38513174-91541C6F-9870-4BAB-A009-9B696A71F157Q38728839-37F92F2D-4331-44F3-94D2-C626B67815B8Q39995398-5A7E0FB0-420D-4FB7-8520-EB38F3F94B1AQ41813002-BAA374FD-DB8F-4129-B6B1-95A0C17D35EDQ42031723-589C68CD-EE3D-41CA-B4D9-31482B565DDDQ42117333-A5C62207-D9F4-4413-828B-8D1A7483C84DQ44941408-4E1BE727-98AA-40B1-BB8B-6A174A5B646EQ45855410-2F99C73F-731F-4F72-AA82-96523C2508A3Q47899284-A138D27B-E0EB-47A1-BDA2-18EC3D0963DBQ51802967-D97215C1-C10A-4D54-9BBB-8DA9FFAD932AQ57238661-060DBF25-2875-4971-B253-3BABABE89B27Q57498734-9C0457BA-9B37-4368-8130-F732B062AE5C
P2860
Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Differentially charged hollow ...... mall interfering RNA delivery.
@ast
Differentially charged hollow ...... mall interfering RNA delivery.
@en
type
label
Differentially charged hollow ...... mall interfering RNA delivery.
@ast
Differentially charged hollow ...... mall interfering RNA delivery.
@en
prefLabel
Differentially charged hollow ...... mall interfering RNA delivery.
@ast
Differentially charged hollow ...... mall interfering RNA delivery.
@en
P2860
P50
P356
P1476
Differentially charged hollow ...... small interfering RNA delivery
@en
P2093
Alexander R Votruba
Jinjun Shi
P2860
P304
P356
10.1002/ANIE.201101554
P407
P577
2011-06-22T00:00:00Z